Stuart C. Gordon

机构：Henry Ford Health, Wayne State University, Henry Ford Hospital, Center for Outcomes Research in Liver Diseases, Global Health Council, Michigan State University · ORCID：0000-0001-8666-3849

发表论文 634 篇 · 总被引 41715 次 · h-index 80

代表论文

• Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC (2026 · Liver International · 被引 2)
• Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient‐Reported Outcomes (2026 · Journal of Gastroenterology and Hepatology · 被引 1)
• Association of food insecurity with metabolic dysfunction-associated steatotic liver disease by sex and race/ethnicity (2026 · European Journal of Nutrition · 被引 1)
• LBO-006 Efficacy and safety of volixibat, an IBAT inhibitor, in patients with primary sclerosing cholangitis and moderate-to-severe pruritus: results of the VISTAS trial (2026 · Journal of Hepatology · 被引 1)
• Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies (2026 · Hepatology Communications · 被引 1)
• Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis (2026 · Alimentary Pharmacology & Therapeutics)